May be taken with or without food. May be taken w/ meals for better absorption & to reduce GI discomfort.
Reconstitution
Intravenous:
Dissolve 500 mg in 10 mL water for inj to make a final vol of 10.4 mL. Further dilute w/ a suitable IV soln for IV infusion.
Intramuscular:
Add 2.5 mL water for inj and shake vigorously (final vol 2.9 mL).
Incompatibility
Blood products, proteinaceous fluids (e.g. protein hydrolysates), IV lipid emulsions, aminoglycosides.
Contraindications
Hypersensitivity to amoxicillin and other penicillins.
Special Precautions
Patient w/ history of β-lactam allergy, infectious mononucleosis. Renal impairment. Pregnancy and lactation.
Adverse Reactions
Nausea, vomiting, diarrhoea, black hairy tongue, serum sickness-like reactions, erythematous maculopapular rashes, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, acute generalised exanthematous pustulosis, hypersensitivity vasculitis, urticaria, increased AST and ALT, cholestatic jaundice, hepatic cholestasis, acute cytolytic hepatitis, crystalluria, anaemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leucopenia, agranulocytosis. Rarely, reversible hyperactivity, agitation, anxiety, insomnia, confusion, convulsions, behavioural changes, dizziness, tooth discolouration.
Potentially Fatal: Anaphylaxis, Clostridium difficile-associated diarrhoea (CDAD) or pseudomembranous colitis.
Pregnancy Category (US FDA)
PO: B
Patient Counseling Information
Maintain adequate fluid intake and urinary output.
MonitoringParameters
Monitor renal, hepatic, and haematologic functions; signs of anaphylaxis during 1st dose.
Overdosage
Symptoms: GI effects (e.g. nausea, vomiting and diarrhoea). Management: Symptomatic treatment w/ attention to water/electrolyte balance.
Drug Interactions
May reduce the efficacy of OC. May increase the effect of anticoagulants. Increased risk of allergic reactions w/ allopurinol. Increased and prolonged blood levels w/ probenecid. Chloramphenicol, macrolides, sulfonamides and tetracyclines may interfere w/ the bactericidal effect of amoxicillin.
Lab Interference
False-positive reactions when testing for the presence of glucose in urine using CLINITEST, Benedict's soln, or Fehling's soln.
Action
Description: Amoxicillin inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall by binding to 1 or more of the penicillin-binding proteins (PBPs), thus inhibiting cell wall biosynthesis resulting in bacterial lysis.
Pharmacokinetics:
Absorption: Rapidly and completely absorbed from the GI tract. Time to peak plasma concentration: 1-2 hr.
Distribution: Widely distributed into body tissues and fluids. Crosses the placenta and enters breast milk (small amounts). Plasma protein binding: Approx 20%.
Metabolism: Undergoes partial hepatic metabolism and converted to penicilloic acid.
Excretion: Via urine (60% as unchanged drug) and faeces. Plasma half-life: 1-1.5 hr.
Chemical Structure
Storage
Store between 20-25°C. Reconstituted oral susp: Store between 2-8°C.
0 Comments